Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Multi-Gyn is a line of over-the-counter vaginal health products, with Multi-Gyn ActiGel being the flagship formulation. The products are based on the patented **2QR-complex**, which consists of bio-active polysaccharides purified from the *Aloe barbadensis* plant. The mechanism of action is physical rather than pharmacological; the 2QR-complex binds to the adhesins on the surface of harmful bacteria and yeast, preventing them from attaching to the vaginal tissue. This neutralization process supports the natural healing of the mucosa and allows beneficial *Lactobacilli* to thrive. Multi-Gyn is primarily used for the treatment and prevention of bacterial vaginosis (BV) and vaginal yeast infections, as well as for relieving symptoms like itching, discharge, and odor. It is classified as a medical device, contains no hormones or preservatives, and is considered safe for use during pregnancy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Multi-Gyn.